Rare lung disease and orphan drug development
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine
Reference67 articles.
1. Care for patients with ultra-rare disorders;Hennekam;Eur J Med Genet,2011
2. Why rare diseases are an important medical and social issue;Schieppati;Lancet,2008
3. Translation of rare disease research into orphan drug development: disease matters;Heemstra;Drug Discov Today,2009
4. The common problem of rare disease in general practice;Knight;Med J Aust,2006
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic applications of carbohydrate-based compounds: a sweet solution for medical advancement;Molecular Diversity;2024-03-30
2. Neighborhood Health and Outcomes in Idiopathic Pulmonary Fibrosis;Annals of the American Thoracic Society;2023-11-14
3. Impacts of adjustment of National Reimbursement Drug List on orphan drugs volume and spending in China: an interrupted time series analysis;BMJ Open;2023-10
4. The Clinical Application of Established and Emerging Biomarkers for Chronic Respiratory Diseases;Journal of Clinical Medicine;2023-09-22
5. Traits, trends and hits of orphan drug designations in cystic fibrosis;Journal of Cystic Fibrosis;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3